Company page

Ucb S.a.

Ucb S.A. is a public company based in Belgium, trading under the ticker UCB. The company has a market capitalization of approximately €54.25 billion. Ucb focuses on biopharmaceuticals, developing innovative treatments for various medical conditions.

profileUCB:EURONEXTAI content: aiUpdated June 24, 2026/company/ucb-sa-1/c-wgvvnycs
Ucb S.a. logo
Ticker
UCB:EURONEXT
Asset type
Stock
Market cap
$54.25B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
EURONEXT
Currency
EUR